Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$580,532
+$105,699 QoQ
Shares Held
4,595
+34.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,314
of 2,266 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $16,989,938 across 13 Drug Manufacturers - General names. GILD ranks #11 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,675 | $3,208,475 | |
| 2 | JNJ |
Johnson & Johnson
|
9,158 | $2,325,857 | |
| 3 | NVS |
Novartis AG
|
14,598 | $2,287,798 | |
| 4 | ABBV |
AbbVie Inc.
|
7,378 | $1,856,599 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,767 | $1,196,594 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,789 | $1,000,886 | |
| 7 | PFE |
Pfizer Inc
|
40,621 | $978,153 | |
| 8 | NVO |
Novo Nordisk A S
|
19,198 | $920,352 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $580,532 | 4,595 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $474,833 | 3,407 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $224,000 | 1,825 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $314,972 | 2,811 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $319,877 | 3,463 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $519,053 | 6,191 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $438,417 | 6,390 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $496,781 | 6,782 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $392,250 | 4,842 | Shares | Sole | 2024-02-28 | |
| No filing history on record for this holder in this stock. | ||||||